New 52 Week Low Today

Enzo Biochem Inc ENZ:NYSE

RT Quote | Last NYSE, VOL From CTA | USD
Last | 04/19/24 EDT
1.09quote price arrow down-0.04 (-3.54%)
Volume
257,881
52 week range
1.07 - 2.74
Loading...
  • Open1.11
  • Day High1.12
  • Day Low1.07
  • Prev Close1.13
  • 52 Week High2.74
  • 52 Week High Date05/11/23
  • 52 Week Low1.07
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap55.836M
  • Shares Out51.23M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-21.58

KEY STATS

  • Open1.11
  • Day High1.12
  • Day Low1.07
  • Prev Close1.13
  • 52 Week High2.74
  • 52 Week High Date05/11/23
  • 52 Week Low1.07
  • 52 Week Low Date04/18/24
  • Market Cap55.836M
  • Shares Out51.23M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-21.58

RATIOS/PROFITABILITY

  • EPS (TTM)-0.47
  • P/E (TTM)-2.32
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-16.317M
  • ROE (TTM)-45.01%
  • Revenue (TTM)32.803M
  • Gross Margin (TTM)42.17%
  • Net Margin (TTM)-71.07%
  • Debt To Equity (MRQ)4.99%

EVENTS

  • Earnings Date06/11/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Enzo Biochem Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures...
Steven Pully CPA
Chairman of the Board
Kara Cannon
Chief Executive Officer, Chief Operating Officer
Patricia Eckert CPA
Chief Financial Officer
Matthew Kupferberg
General Counsel, Secretary
Address
60 EXECUTIVE BLVD
Farmingdale, NY
11735
United States

Top Peers

SYMBOLLASTCHG%CHG
SPRO
Spero Therapeutics Inc
1.40-0.07-4.76%
CTMX
CytomX Therapeutics Inc
1.67-0.06-3.47%
FBIO
Fortress Biotech Inc
1.75-0.06-3.31%
HBIO
Harvard Bioscience Inc
3.70-0.27-6.80%
PSNL
Personalis Inc
1.29+0.08+6.61%